<DOC>
	<DOCNO>NCT01072812</DOCNO>
	<brief_summary>This trial determine pharmacokinetics Posiphen® plasma CSF 10-day treatment period Posiphen® subject amnestic MCI . The effect treatment biomarkers also determine CSF , whole blood , plasma serum primary pharmacodynamic ( PD ) objectives .</brief_summary>
	<brief_title>Study Pharmacokinetics Pharmacodynamics POSIPHEN® Subjects With Amnestic Mild Cognitive Impairment</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Physostigmine</mesh_term>
	<criteria>1 . Males postmenopausal female age 55 80 year , inclusive . 2 . Must Mild Cognitive Impairment ( MCI ) ( amnestic subtype ) accord Petersen 's criterion ( 2004 ) . 3 . Mini Mental Status Examination ( MMSE ) score ≥24 . 4 . Must score predetermine cutoff score logical memory II delay paragraph recall subtest Wechsler Memory Scale Revised ( WMSR ) . 5 . Must Clinical Dementia Rating 0.5 memory box score 0.5 1.0 . 6 . Modified Hachinski score less equal 4 . 7 . Hamilton Depression rating scale ( HAMD17 ) score less equal 12 score 0 item 1 , 2 , 3 ( depressed mood , feeling guilt , suicidal ideation ) . 8 . No evidence current suicidal ideation previous suicide attempt past 2 year evaluate Columbia Suicidality Checklist . 9 . MRI scan within 12 month prior screen , per screen MRI , without evidence infection , infarction , focal lesion without clinical symptom suggestive intervene neurological disease . 10 . No clinically significant abnormality lumbar spine present lumbar Xray would contraindicate lumbar puncture . 11 . Adequate visual hearing ability ( physical ability perform study assessment ) . 12 . Normal B12 , folic acid , thyroid function test ( thyroid stimulate hormone [ TSH ] , free T4 , free T3 ) . 13 . Do require nursing home care . 1 . Any significant neurologic disease amnestic MCI , history significant head trauma follow persistent neurologic deficit know structural brain abnormality . 2 . Major depression , schizophrenia another major psychiatric disorder describe Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) within past 2 year . 3 . Psychotic feature , agitation , behavioral problem within last 3 month could lead difficulty comply protocol . 4 . History alcohol substance abuse dependence within past 2 year . 5 . Subjects febrile illness within 1 week prior CSF collection . 6 . Subjects history migraine headache type headache least moderate severity twice per month . 7 . Any significant systemic illness unstable medical condition could lead difficulty comply protocol pose potential risk subject . 8 . Use medication prohibit study . 9 . Any clinically significant laboratory abnormality . 10 . Subjects infection inflammation skin skin disease proximity lumbar puncture site . 11 . History lumbar spine surgery chronic low back pain ( CLBP ) .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Alzheimer 's</keyword>
	<keyword>Amnestic Mild Cognitive Impairment</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Biomarkers</keyword>
</DOC>